Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 15 years of delivering hope through knowledge.
[My emphasis]Statins may only have modest effects over extended periods which would require long-term (>5years) and large-scale trials. These would prove very expensive and therefore not attractive to the pharmaceutical industry. This is especially pertinent where statins have lost, or will soon lose, patent protection.